Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Granoff

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Vaccine|September 17, 2013
Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic miceRaffaella Rossi, Dan M Granoff, Peter T Beernink
Clinical and Vaccine Immunology : CVI|June 7, 2013
Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?Dan M Granoff, Sanjay Ram, Peter T Beernink
Vaccine|June 25, 2013
fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutationsSerena Giuntini, David M Vu, Dan M Granoff
Clinical and Vaccine Immunology : CVI|July 11, 2006
Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidatePeter T Beernink, Arunas Leipus, Dan M Granoff
Infection and Immunity|March 24, 2005
Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibodyGregory R Moe, Apurva Dave, Dan M Granoff
Infection and Immunity|June 29, 2011
Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H bindingSerena Giuntini, Donald C Reason, Dan M Granoff
Infection and Immunity|November 9, 2011
Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding proteinSerena Giuntini, Donald C Reason, Dan M Granoff
The Journal of Infectious Diseases|May 30, 2013
Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccinesMonica Konar, Dan M Granoff, Peter T Beernink
Molecular Immunology|September 6, 2005
Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodiesGregory R Moe, Apurva Dave, Dan M Granoff
Vaccine|June 1, 2005
Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old childrenDan M Granoff, Amy Morgan, Jo Anne Welsch
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Vaccine|September 17, 2013
Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic miceRaffaella Rossi, Dan M Granoff, Peter T Beernink
Clinical and Vaccine Immunology : CVI|June 7, 2013
Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?Dan M Granoff, Sanjay Ram, Peter T Beernink
Vaccine|June 25, 2013
fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutationsSerena Giuntini, David M Vu, Dan M Granoff
Clinical and Vaccine Immunology : CVI|July 11, 2006
Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidatePeter T Beernink, Arunas Leipus, Dan M Granoff
Infection and Immunity|March 24, 2005
Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibodyGregory R Moe, Apurva Dave, Dan M Granoff
Infection and Immunity|June 29, 2011
Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H bindingSerena Giuntini, Donald C Reason, Dan M Granoff
Infection and Immunity|November 9, 2011
Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding proteinSerena Giuntini, Donald C Reason, Dan M Granoff
The Journal of Infectious Diseases|May 30, 2013
Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccinesMonica Konar, Dan M Granoff, Peter T Beernink
Molecular Immunology|September 6, 2005
Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodiesGregory R Moe, Apurva Dave, Dan M Granoff
Vaccine|June 1, 2005
Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old childrenDan M Granoff, Amy Morgan, Jo Anne Welsch
Pageof 10